Canada Research Roundup: Andlauer Healthcare Group, Medipharm Labs, Valens Company

Andlauer Healthcare

06/07/2020 12:41

July 6 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian
companies, including Andlauer Healthcare Group, Medipharm Labs and Valens Company, on Monday. 
    
    
  HIGHLIGHTS
     * Andlauer Healthcare Group  AND.TO : NBC starts with sector perform rating; PT C$35.25
     * Medipharm Labs  LABS.TO : Canaccord Genuity resumes coverage with speculative buy rating 
     * Protech Home Medical  PTQ.V : Canaccord Genuity initiates coverage with buy rating 
     * Valens Company  VLNS.TO : Canaccord Genuity resumes coverage with speculative buy rating 
 
Following is a summary of research actions on Canadian companies reported by Reuters on Monday. Stock
entries are in alphabetical order. 
     
     * Andlauer Healthcare Group  AND.TO : NBC starts with sector perform rating; PT C$35.25
     * Endeavour Mining  EDV.TO : BMO resumes coverage with outperform rating and C$45 PT
     * Ensign Energy Services Inc  ESI.TO : Evercore ISI cuts target price to C$0.50 from C$1
     * Medipharm Labs  LABS.TO : Canaccord Genuity resumes coverage with speculative buy rating 
     * Medipharm Labs  LABS.TO : Canaccord Genuity resumes coverage with price target of C$2.25
     * Organigram Holdings Inc  OGI.TO : Jefferies cuts target price to C$4.50 from C$5.00
     * Precision Drilling Corp  PD.TO : Evercore ISI cuts target price to C$1 from C$1.25
     * Protech Home Medical  PTQ.V : Canaccord Genuity initiates coverage with buy rating 
     * Protech Home Medical  PTQ.V : Canaccord Genuity initiates coverage with C$2 price target
     * Shaw Communications Inc  SJRb.TO : Scotiabank cuts target price to C$1.30 from C$1.31
     * Valens Company  VLNS.TO : Canaccord Genuity resumes coverage with speculative buy rating 
     * Valens Company  VLNS.TO : Canaccord Genuity resumes coverage with price target of C$6.50
         

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))